標題: Titlebook: Bone Metastases from Prostate Cancer; Biology, Diagnosis a Francesco Bertoldo,Francesco Boccardo,Riccardo Val Book 2017 Springer Internatio [打印本頁] 作者: CHORD 時間: 2025-3-21 17:33
書目名稱Bone Metastases from Prostate Cancer影響因子(影響力)
書目名稱Bone Metastases from Prostate Cancer影響因子(影響力)學科排名
書目名稱Bone Metastases from Prostate Cancer網(wǎng)絡公開度
書目名稱Bone Metastases from Prostate Cancer網(wǎng)絡公開度學科排名
書目名稱Bone Metastases from Prostate Cancer被引頻次
書目名稱Bone Metastases from Prostate Cancer被引頻次學科排名
書目名稱Bone Metastases from Prostate Cancer年度引用
書目名稱Bone Metastases from Prostate Cancer年度引用學科排名
書目名稱Bone Metastases from Prostate Cancer讀者反饋
書目名稱Bone Metastases from Prostate Cancer讀者反饋學科排名
作者: 蒙太奇 時間: 2025-3-21 20:58 作者: 智力高 時間: 2025-3-22 03:39 作者: 對手 時間: 2025-3-22 07:38 作者: genesis 時間: 2025-3-22 10:09 作者: atopic 時間: 2025-3-22 14:58 作者: 胰島素 時間: 2025-3-22 18:15
Book 2017 and research, and the authors are experts in diverse specialties. This ensures a multidisciplinary approach, mirroring the current situation in which treatment in patients with bone metastases is undertaken by a team of specialists and health professionals in a variety of fields..作者: nutrition 時間: 2025-3-22 23:56
ciplinary approach, mirroring the current situation in which treatment in patients with bone metastases is undertaken by a team of specialists and health professionals in a variety of fields..978-3-319-82553-3978-3-319-42327-2作者: Fermentation 時間: 2025-3-23 03:26 作者: Osteons 時間: 2025-3-23 07:20
https://doi.org/10.1007/978-1-4684-2022-7eatment when compared with conventional bone scan. Furthermore, .F-NaF PET/CT exhibits the occult metastases more accurately in lower PSA level..Recently, the combination of .F-NaF with other specific PET tracers (e.g., .F-choline) in a single PET/CT (i.e., dual tracer PET/CT) is introduced as a pro作者: Boycott 時間: 2025-3-23 13:41
,Durchführung der Lithiumtherapie,synthesis, inhibitors of adrenal androgen synthesis, and first and second generation of antiandrogens. These agents exert a good control of the disease in terms of both overall survival and reduction in the incidence and severity of skeletal adverse events. In hormone-na?ve patients, luteinizing hor作者: 憤世嫉俗者 時間: 2025-3-23 17:51 作者: largesse 時間: 2025-3-23 21:07 作者: Atheroma 時間: 2025-3-24 01:24 作者: DNR215 時間: 2025-3-24 03:29
Circulating Tumor Cells (CTCs) and Metastatic Prostate Cancer (mPCa),g tumor cells (CTCs) meet the criteria required for a surrogate endpoint, particularly in mPCa..The main open question about the clinical management of mPCa is discussed, with the intent to underscore how the extended use of CTC detection and characterization can offer further benefit to these patients.作者: 謙卑 時間: 2025-3-24 08:27
Book 2017respect to biology, pathology, diagnosis, and treatment are described, providing readers with an excellent understanding of the mechanisms of metastasis formation, the characteristics of metastases, their aggressiveness, and prognostic factors for treatment response. The coverage includes discussion作者: Arteriography 時間: 2025-3-24 10:39
Preparations, Dosage, and Control,g tumor cells (CTCs) meet the criteria required for a surrogate endpoint, particularly in mPCa..The main open question about the clinical management of mPCa is discussed, with the intent to underscore how the extended use of CTC detection and characterization can offer further benefit to these patients.作者: LIEN 時間: 2025-3-24 15:51
Studies in Human Ecology and Adaptationr PFS and OS than those with 5–20 BMTs [4]. It should, however, be taken into account that among the predictors of prognosis, coexisting non-osseous metastatic disease is an important determinant of prognosis in patients with BMTs [5, 6].作者: 報復 時間: 2025-3-24 20:41 作者: 財主 時間: 2025-3-25 01:42 作者: 精確 時間: 2025-3-25 07:06 作者: 桶去微染 時間: 2025-3-25 08:14
Miscellaneous Tools/Implements,ce to key clinical scenarios. We considered the initial assessment of the risk of developing bone metastases, the early detection of relapse during the follow-up, and the management of the relapse; this latter issue is discussed considering separately patients with biochemical relapse and those with manifest clinical metastases.作者: vocation 時間: 2025-3-25 14:47 作者: CLAM 時間: 2025-3-25 18:42 作者: 難解 時間: 2025-3-25 20:05 作者: 騙子 時間: 2025-3-26 01:22 作者: Exonerate 時間: 2025-3-26 08:19 作者: BOOR 時間: 2025-3-26 09:14 作者: 憤憤不平 時間: 2025-3-26 14:43 作者: 使長胖 時間: 2025-3-26 20:20
Detection of Bone Metastases and Evaluation of Therapy Response in Prostate Cancer Patients by Radi disease is present and not detected on current imaging studies, including bone scan and computed tomography scan. Molecular imaging approaches and, in particular Choline positron emission tomography, have been investigated to improve the detection of metastatic disease in patients with prostate cancer.作者: 偽善 時間: 2025-3-26 23:45
Imaging of Glycolysis with 18F-FDG PET,alignancy-induced hypermetabolism is generally based upon overexpression of cellular membrane glucose transporters (mainly glucose transporter 1, GLUT-1) and enhanced hexokinase enzymatic activity in tumors [1, 2].作者: endoscopy 時間: 2025-3-27 05:04 作者: Affiliation 時間: 2025-3-27 08:46
Studies in Human Ecology and Adaptationntigraphy or the distribution of BMTs (axial vs appendicular) with survival in patients with advanced prostate cancer (PC) [1, 2]. The number of BMTs has recently been evaluated as a prognostic predictor [3]. Patients with metastatic castration-resistant PC with a higher number of BMTs had a shorter作者: hypotension 時間: 2025-3-27 09:54
https://doi.org/10.1007/978-3-319-64407-3e formation of new bone by osteoblasts. Local and systemic growth factors regulate the differentiation and activity of the osteoclasts and osteoblasts (and osteocytes). Maintenance and repair of normal bone result in the release of enzymes, peptides and mineral components that have been characterise作者: reserve 時間: 2025-3-27 17:18
Miscellaneous Tools/Implements,cuss the contemporary notion of tumor markers from a general point of view. We focus on some specific characteristics of prostate-specific antigen (PSA), showing why it is the sole circulating tumor marker presently recommended in the follow-up of patients – with or without metastases – treated with作者: jagged 時間: 2025-3-27 18:33 作者: Gudgeon 時間: 2025-3-27 23:54 作者: 不能強迫我 時間: 2025-3-28 04:59 作者: 不要嚴酷 時間: 2025-3-28 09:32 作者: analogous 時間: 2025-3-28 14:03
,Durchführung der Lithiumtherapie,-18F-fluorocyclobutane-1-carboxylic acid (.F-FACBC) or probe targeting the prostate-specific membrane antigen (PSMA). These radiotracers showed in literature better performance in the detection of prostate cancer recurrence as compared to choline PET/CT imaging [1, 2].作者: athlete’s-foot 時間: 2025-3-28 16:24
,Durchführung der Lithiumtherapie,l events, like bone fractures or spinal cord compression, which complicate the course of disease and can further shorten their life expectancy; furthermore, these events are usually associated with pain and other troublesome symptoms, which can seriously affect patients’ quality of life and become a作者: PACK 時間: 2025-3-28 20:51
Prophylaxe rezidivierender Depressionen,the state known as metastatic castration-resistant prostate cancer (mCRPC). For nearly a decade, chemotherapy with docetaxel has been the only established standard of care in this setting. In recent years, treatment of mCRPC has changed dramatically due to the improvement in the understanding of CRP作者: 舊石器時代 時間: 2025-3-29 00:44
Prophylaxe bipolarer affektiver Krankheiten,ases, patients have localized disease at presentation, which may be successfully treated with radical prostatectomy and external beam radiation. However, many patients subsequently develop metastatic disease. De novo metastases can also occur in a minority of cases.Androgen deprivation therapy (ADT)作者: ANTIC 時間: 2025-3-29 06:33
,Unerwünschte Wirkungen auf Organsysteme,ium has been found efficacious in the treatment of cancer. At the end of the 1960s, with the growth of high-energy radiation units, modern techniques of external beam irradiation (external beam radiation therapy (EBRT)) started to be routinely used. In subsequent years, technological evolution enabl作者: Analogy 時間: 2025-3-29 09:44
Prophylaxe bipolarer affektiver Krankheiten,ases [17]. Recently abiraterone and enzalutamide have demonstrated potential beneficial effects on bone metabolism delaying and reducing skeletal complications. Even with recent improvements in medical treatment of skeletal metastases in prostate cancer, the development of effective and precise ther作者: Glucocorticoids 時間: 2025-3-29 12:39 作者: NOMAD 時間: 2025-3-29 16:27 作者: 拘留 時間: 2025-3-29 21:08 作者: intellect 時間: 2025-3-30 00:51 作者: Neolithic 時間: 2025-3-30 05:42
New Frontiers in Treatment,volvement of more than 80 %, the bone represents the preferential site of metastases for this disease. As a consequence, patients experiencing advanced stage castration-resistant prostate cancer (CRPC) are at increased risk of developing skeletal-related events, including pathologic fractures and spinal cord compression [2].作者: 附錄 時間: 2025-3-30 11:45 作者: PAD416 時間: 2025-3-30 14:46 作者: 柔軟 時間: 2025-3-30 16:34 作者: sterilization 時間: 2025-3-30 21:03
Bone Homing and Metastasis,Bone metastasization is a frequent event for a variety of cancer cells, including breast, prostate, lung, and thyroid tumors. In these diseases, the rate of bone involvement can overcome 70 %, for a total of more than 350,000 patients/year died in the United States with bone metastasis (BMs) [1, 2].作者: 委托 時間: 2025-3-31 04:07
Surgery: Treatment of Oligometastatic Disease,The treatment of the patient with bone metastases from prostate cancer is usually based on medical and radiation therapy [1–6]. Nevertheless, sometimes indication for surgery is present with:作者: transdermal 時間: 2025-3-31 05:08 作者: ANT 時間: 2025-3-31 12:37
Francesco Bertoldo,Francesco Boccardo,Riccardo ValEquips readers with an excellent understanding of metastasis formation and prognostic factors.Explains how best to achieve early diagnosis.Presents the latest evidence from the literature and clinical作者: Subjugate 時間: 2025-3-31 14:08 作者: Angioplasty 時間: 2025-3-31 18:33
https://doi.org/10.1007/978-3-319-42327-2Bone-targeted agents; Markers of prostate cancer; Formation of bone metastases; Nuclear medicine techni作者: exostosis 時間: 2025-3-31 22:41 作者: 染色體 時間: 2025-4-1 02:49 作者: 托運 時間: 2025-4-1 06:43 作者: audiologist 時間: 2025-4-1 12:16
Biology and Pathophysiology of Bone Metastasis in Prostate Cancer,ntigraphy or the distribution of BMTs (axial vs appendicular) with survival in patients with advanced prostate cancer (PC) [1, 2]. The number of BMTs has recently been evaluated as a prognostic predictor [3]. Patients with metastatic castration-resistant PC with a higher number of BMTs had a shorter
